Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemiaElena J. Orlando, Wendy Winckler, Xia Han et al.|Nature Medicine|2018Cited by 577
Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell functionJennifer L. Brogdon, Qian Huang, YongYao Xu et al.|Blood|2006Cited by 226
Cytokine Release Syndrome Results in Reduced AML Killing By CD123 CAR T CellsAnand Bhagwat, Saar Gill, Selina M. Luger et al.|Blood|2023Cited by 5